期刊档案 · Medicine-Oncology

Forum of Clinical Oncology

ISSN 1792-345X · eISSN 1792-362X · Hellenic Society of Medical Oncology (He.S.M.O.) · Poland

Forum of Clinical Oncology 完全开放获取,免版面费,投稿社区反馈审稿约 6 周,2025 年发文 10 篇,Scopus 收录。

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区Q4Oncology · 排名 394/428 · 百分位 8%
审稿周期约 6 周投稿社区平均反馈
版面费免版面费完全开放获取
录用比例—暂无反馈
年发文量10 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Forum of Clinical Oncology 由 Hellenic Society of Medical Oncology (He.S.M.O.) 出版。按 OpenAlex 近年发文统计,该刊主要发表 Breast Cancer Treatment Studies、Cancer Immunotherapy and Biomarkers、Lung Cancer Diagnosis and Treatment 等主题的论文,这 3 个主题约占 24.1%,主导子领域为 Oncology、Pulmonary and Respiratory Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)

Why subscribe and readWe would like to present to you the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology.In the Hellenic Society of Medical Oncology we want FCO to serve as a forum, for us all, to communicate clinical and research achievements in English; to share thoughts, opinions, facts, problems and solutions.We envision the journal to be the means, by which our efforts in the fight against cancer will become known to a wider audience, thus establishing our presence in the global setting. FCO publishes original and translational research articles relevant to diagnosis and treatment of cancer, state-of-the-art reviews, case reports, research articles, statements of opinion and comments, all related to clinical practice and basic research. A large number of eminent Greek and Foreign colleagues who participate in the National and International Editorial Boards, with their continuum direction and support, guarantee the high quality of the work published in FCO. In every issue published there will be something new, enjoyable and exciting to be read.Why submitWe would like to welcome you to the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology.In the Hellenic Society of Medical Oncology we share the view that there are many issues we deal with in our everyday clinical and research practice that are common to our colleagues geographically closer to us, in the Balkans and the Mediterranean basin, but also to those in other parts of the world. That led us to dare "the great leap forward": to broaden the scope of our Greek scientific journal for oncology, published in Greek for the last 10 years, and develop Forum of Clinical Oncology a web based open access journal in English.FCO will serve as a forum for us all to communicate clinical and research achievements. One of the innovations of the journal is its online management from submission of an article to its publication. Online is more efficient: submitting, reviewing, proofreading, filing and indexing. However, the most important benefit of all is easy universal access.English has become the common language amongst scientists from around the globe. This is the reason why we chose English as the official language of the journal. Many Greek colleagues have already published work in English in distinguished journals or have studied or worked abroad. We believe that the language change will

摘自期刊官网 Aims & Scope

研究方向(LetPub):Medicine-Oncology

主编 Nikolaos Tsoukalas出版商官网

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology11.6%
  2. Cancer Immunotherapy and BiomarkersMedicine6.5%
  3. Lung Cancer Diagnosis and TreatmentMedicine6%
  4. Breast Lesions and CarcinomasMedicine6%
  5. Lung Cancer Treatments and MutationsMedicine5.5%
  6. Head and Neck Cancer StudiesMedicine5%
  7. Colorectal Cancer Treatments and StudiesMedicine5%
  8. Colorectal Cancer Surgical TreatmentsMedicine4%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

CiteScore 分区(Scopus,2026 年 6 月版)

学科分区排名百分位
OncologyQ4394/4288%

Scopus 按 CiteScore 在每个学科内为期刊排名,百分位 75 及以上为 Q1,每 25 为一档;与中科院分区是不同体系。LetPub

数据库收录

ScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

CiteScore 2026-06
0.3LetPub ·
CiteScore(出版商公布)
0.3出版商官网 ·
SJR 2026-06
0.12LetPub ·
SNIP 2026-06
0.09LetPub ·
h-index
7OpenAlex ·
i10-index
3OpenAlex ·
两年平均被引
0.34OpenAlex ·
Gold OA 文章占比
0%LetPub ·

逐年发文量 OpenAlex 统计 · 累计 169 篇 · 当年数据不完整

年份发文量其中 OA被引
2026121229
2025101036
2024131325
2023232325
2022222225
2021232332

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
6 WeeksLetPub ·
评审方式
同行评审LetPub

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取OpenAlex

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
LetPub无文章处理费无—

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

官网政策摘录许可与版权
许可与版权 Copyright 2026 © Paradigm. All rights reserved.

Currency:EUR €USD $GBP £ Terms of servicePrivacy policyEthical policiesAccessibility

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Hellenic Society of Medical Oncology (He.S.M.O.)
出版国家或地区
Poland
出版语言
English
ISSN
1792-345X
电子版 ISSN
1792-362X
官方链接

常见问题

关于 Forum of Clinical Oncology 的常见问题

Forum of Clinical Oncology 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 6 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Forum of Clinical Oncology 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Forum of Clinical Oncology 被 Scopus、DOAJ 收录。

Forum of Clinical Oncology 是开放获取期刊吗?版面费多少?

Forum of Clinical Oncology 为完全开放获取。不收取文章处理费。

来源与更新

本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-28 归档)。最近更新:。